{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:26:25Z","timestamp":1777717585420,"version":"3.51.4"},"posted":{"date-parts":[[2025,5,12]]},"group-title":"In Review","reference-count":64,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,4,24]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  We present the Full-Spectrum Generative Lead Discovery (FSGLD), a deep learning-driven pipeline for efficient drug lead identification. FSGLD integrates generative modeling with molecular docking, molecular dynamics simulations, ligand-residue interaction profile, MM-PBSA, thermodynamic integration (TI), and experimental validation to bridge theoretical design and practical application. The core multiscale DRUG-GAN models enable\n                  <italic>de novo<\/italic>\n                  design for both drug-like and target-specific compounds across three scenarios: I. generation of random drug-like compounds, II. generation of target-specific compounds, III. generation of target-biased compound series featuring shared chemical structures. FSGLD significantly outperformed traditional computer-aided drug design methods in generating novel chemicals which specifically target the CB2 receptor. Additionally, a computational protocol for TI calculations was established to reduce computation time by 80\u201390% while maintaining accuracy. By integrating generative models with\n                  <italic>in silico<\/italic>\n                  and\n                  <italic>in vitro<\/italic>\n                  evaluation techniques, FSGLD reduces the cost of identifying novel yet viable lead compounds, offering remarkable benefits to both academic and industry.\n                <\/p>","DOI":"10.21203\/rs.3.rs-6516504\/v1","type":"posted-content","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T23:22:34Z","timestamp":1747005754000},"source":"Crossref","is-referenced-by-count":0,"title":["A Full-Spectrum Generative Lead Discovery (FSGLD) Pipeline via DRUG-GAN: A Multiscale Method for Drug-like\/Target-specific Compound Library Generation"],"prefix":"10.21203","author":[{"given":"Junmei","family":"Wang","sequence":"first","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beihong","family":"Ji","sequence":"additional","affiliation":[{"name":"Hangzhou Institute of Medicine, Chinese Academy of Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Brock","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhui","family":"Wu","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuemin","family":"Bian","sequence":"additional","affiliation":[{"name":"Broad Institute of MIT and Harvard"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7431-7893","authenticated-orcid":false,"given":"Xibing","family":"He","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: New estimates of R&D costs","volume":"47","author":"DiMasi JA","year":"2016","unstructured":"DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: New estimates of R&D costs. J Health Econ 47:20\u201333. https:\/\/doi.org:10.1016\/j.jhealeco.2016.01.012","journal-title":"J Health Econ"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009\u20132018","volume":"323","author":"Wouters OJ","year":"2020","unstructured":"Wouters OJ, McKee M, Luyten J (2020) Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009\u20132018. JAMA 323:844\u2013853. https:\/\/doi.org:10.1001\/jama.2020.1166","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-013-9672-4","article-title":"Estimation of the size of drug-like chemical space based on GDB-17 data","volume":"27","author":"Polishchuk P","year":"2013","unstructured":"Polishchuk P, Madzhidov T, Varnek A (2013) Estimation of the size of drug-like chemical space based on GDB-17 data. J Comput Aided Mol Des 27. https:\/\/doi.org:10.1007\/s10822-013-9672-4","journal-title":"J Comput Aided Mol Des"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nchembio.180","article-title":"Quantifying biogenic bias in screening libraries","volume":"5","author":"Hert J","year":"2009","unstructured":"Hert J, Irwin JJ, Laggner C, Keiser MJ, Shoichet BK (2009) Quantifying biogenic bias in screening libraries. Nat Chem Biol 5:479\u2013483. https:\/\/doi.org:10.1038\/nchembio.180","journal-title":"Nat Chem Biol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira LG","year":"2015","unstructured":"Ferreira LG, Santos D, Oliva RN, G., Andricopulo AD (2015) Molecular docking and structure-based drug design strategies. Mol 20:13384\u201313421. https:\/\/doi.org:10.3390\/molecules200713384","journal-title":"Mol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/acscentsci.7b00512","article-title":"Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks","volume":"4","author":"Segler MHS","year":"2018","unstructured":"Segler MHS, Kogej T, Tyrchan C, Waller MP (2018) Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks. ACS Cent Sci 4:120\u2013131. https:\/\/doi.org:10.1021\/acscentsci.7b00512","journal-title":"ACS Cent Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/minf.201700111","author":"Gupta A","year":"2018","unstructured":"Gupta A et al (2018) Generative Recurrent Networks for De Novo Drug Design. Molecular informatics 37 https:\/\/doi.org:10.1002\/minf.201700111"},{"key":"ref8","author":"Song HD","year":"2018","unstructured":"Song HD (2018) a. Y. T. a. B. D. a. S. S. a. L. Syntax-Directed Variational Autoencoder for Structured Data}. arXiv 1802.08786"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","article-title":"Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules","volume":"4","author":"G\u00f3mez-Bombarelli R","year":"2018","unstructured":"G\u00f3mez-Bombarelli R et al (2018) Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules. ACS Cent Sci 4:268\u2013276. https:\/\/doi.org:10.1021\/acscentsci.7b00572","journal-title":"ACS Cent Sci"},{"key":"ref10","author":"Aspuru-Guzik GLG","year":"2018","unstructured":"Aspuru-Guzik GLG (2018) a. B. S.-L. a. C. O. a. P. L. C. F. a. A. Objective-Reinforced Generative Adversarial Networks (ORGAN) for Sequence Generation Models. arXiv 1705.10843"},{"key":"ref11","author":"Hern\u00e1ndez-Lobato MJK","year":"2017","unstructured":"Hern\u00e1ndez-Lobato MJK (2017) a. B. P. a. J. M. Grammar Variational Autoencoder. arXiv 1703.01925"},{"key":"ref12","author":"Gomez-Rodriguez BS","year":"2019","unstructured":"Gomez-Rodriguez BS (2019) a. A. D. a. G. J. a. P. K. C. a. N. G. a. M. NeVAE: A Deep Generative Model for Molecular Graphs. arXiv 1802.05283"},{"key":"ref13","author":"Jaakkola WJ","year":"2019","unstructured":"Jaakkola WJ (2019) a. R. B. a. T. Junction Tree Variational Autoencoder for Molecular Graph Generation. arXiv 1802.04364"},{"key":"ref14","author":"Kipf NDC","year":"2018","unstructured":"Kipf NDC (2018) a. T. MolGAN: An implicit generative model for small molecular graphs. arXiv 1805.11973"},{"key":"ref15","author":"Komodakis MS","year":"2018","unstructured":"Komodakis MS (2018) a. N. GraphVAE: Towards Generation of Small Graphs Using Variational Autoencoders. arXiv 1802.03480"},{"key":"ref16","author":"Leskovec JY","year":"2019","unstructured":"Leskovec JY (2019) a. B. L. a. R. Y. a. V. P. a. J. Graph Convolutional Policy Network for Goal-Directed Molecular Graph Generation. arXiv 1806.02473"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12859-024-05810-w","article-title":"Equivariant score-based generative diffusion framework for 3D molecules","volume":"25","author":"Zhang H","year":"2024","unstructured":"Zhang H, Liu Y, Liu X, Wang C, Guo M (2024) Equivariant score-based generative diffusion framework for 3D molecules. BMC Bioinformatics 25:203. https:\/\/doi.org:10.1186\/s12859-024-05810-w","journal-title":"BMC Bioinformatics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"10883","DOI":"10.18632\/oncotarget.14073","article-title":"The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology","volume":"8","author":"Kadurin A","year":"2017","unstructured":"Kadurin A et al (2017) The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology. Oncotarget 8:10883\u201310890. https:\/\/doi.org:10.18632\/oncotarget.14073","journal-title":"Oncotarget"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1021\/acs.molpharmaceut.9b00500","article-title":"Deep Convolutional Generative Adversarial Network (dcGAN) Models for Screening and Design of Small Molecules Targeting Cannabinoid Receptors","volume":"16","author":"Bian Y","year":"2019","unstructured":"Bian Y, Wang J, Jun JJ, Xie X-Q (2019) Deep Convolutional Generative Adversarial Network (dcGAN) Models for Screening and Design of Small Molecules Targeting Cannabinoid Receptors. Mol Pharm 16:4451\u20134460. https:\/\/doi.org:10.1021\/acs.molpharmaceut.9b00500","journal-title":"Mol Pharm"},{"key":"ref20","first-page":"4181","article-title":"E (n) equivariant normalizing flows","volume":"34","author":"Garcia Satorras V","year":"2021","unstructured":"Garcia Satorras V, Hoogeboom E, Fuchs F, Posner I, Welling M (2021) E (n) equivariant normalizing flows. Adv Neural Inf Process Syst 34:4181\u20134192","journal-title":"Adv Neural Inf Process Syst"},{"key":"ref21","author":"Hoogeboom E","unstructured":"Hoogeboom E, Satorras VG, Vignac C, Welling M in International conference on machine learning. 8867\u20138887 (PMLR)"},{"key":"ref22","author":"Satorras VG","unstructured":"Satorras VG, Hoogeboom E, Welling M in International conference on machine learning. 9323\u20139332 (PMLR)"},{"key":"ref23","author":"Goodfellow IaP-A","year":"2014","unstructured":"Goodfellow IaP-A (2014) Jean and Mirza, Mehdi and Xu, Bing and Warde-Farley, David and Ozair, Sherjil and Courville, Aaron and Bengio, Yoshua. Generative Adversarial Nets. Vol. 27Curran Associates, Inc"},{"key":"ref24","author":"Denton E","year":"2015","unstructured":"Denton E, Chintala S, Szlam A, Fergus R (2015) in Proceedings of the 28th International Conference on Neural Information Processing Systems - Volume 1 1486\u20131494MIT Press, Montreal, Canada"},{"key":"ref25","author":"Chintala AR","year":"2016","unstructured":"Chintala AR (2016) a. L. M. a. S. Unsupervised Representation Learning with Deep Convolutional Generative Adversarial Networks. arXiv 1511.06434"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13321-019-0397-9","article-title":"A de novo molecular generation method using latent vector based generative adversarial network","volume":"11","author":"Prykhodko O","year":"2019","unstructured":"Prykhodko O et al (2019) A de novo molecular generation method using latent vector based generative adversarial network. J Cheminform 11:74. https:\/\/doi.org:10.1186\/s13321-019-0397-9","journal-title":"J Cheminform"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13321-019-0404-1","article-title":"Mol-CycleGAN: a generative model for molecular optimization","volume":"12","author":"Maziarka \u0141","year":"2020","unstructured":"Maziarka \u0141 et al (2020) Mol-CycleGAN: a generative model for molecular optimization. J Cheminform 12:2. https:\/\/doi.org:10.1186\/s13321-019-0404-1","journal-title":"J Cheminform"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41467-019-13807-w","article-title":"De novo generation of hit-like molecules from gene expression signatures using artificial intelligence","volume":"11","author":"M\u00e9ndez-Lucio O","year":"2020","unstructured":"M\u00e9ndez-Lucio O, Baillif B, Clevert D-A, Rouqui\u00e9 D, Wichard J (2020) De novo generation of hit-like molecules from gene expression signatures using artificial intelligence. Nat Commun 11:10. https:\/\/doi.org:10.1038\/s41467-019-13807-w","journal-title":"Nat Commun"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13321-022-00623-6","article-title":"Designing optimized drug candidates with Generative Adversarial Network","volume":"14","author":"Abbasi M","year":"2022","unstructured":"Abbasi M et al (2022) Designing optimized drug candidates with Generative Adversarial Network. J Cheminform 14:40. https:\/\/doi.org:10.1186\/s13321-022-00623-6","journal-title":"J Cheminform"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun Y","year":"2015","unstructured":"LeCun Y, Bengio Y, Hinton G (2015) Deep learning. Nature 521:436\u2013444. https:\/\/doi.org:10.1038\/nature14539","journal-title":"Nature"},{"key":"ref31","author":"Krizhevsky A","year":"2012","unstructured":"Krizhevsky A, Sutskever I, Hinton GE (2012) in Proceedings of the 25th International Conference on Neural Information Processing Systems - Volume 1 1097\u20131105Curran Associates Inc., Lake Tahoe, Nevada"},{"key":"ref32","author":"Zeiler MD","unstructured":"Zeiler MD, Fergus R in Computer Vision \u2013 ECCV 2014. (eds David Fleet, Tomas Pajdla, Bernt Schiele, & Tinne Tuytelaars) 818\u2013833 (Springer International Publishing)"},{"key":"ref33","author":"Zisserman KS","year":"2015","unstructured":"Zisserman KS (2015) a. A. Very Deep Convolutional Networks for Large-Scale Image Recognition. arXiv 1409.1556"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"gkad1004","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods","author":"Zdrazil B","year":"2023","unstructured":"Zdrazil B et al (2023) The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res gkad1004. https:\/\/doi.org:10.1093\/nar\/gkad1004","journal-title":"Nucleic Acids Res"},{"key":"ref35","author":"Mirza M","year":"2014","unstructured":"Mirza M, Osindero S (2014) Conditional generative adversarial nets. arXiv preprint arXiv:1411.1784"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s13369-021-05796-0","article-title":"Conditional Deep Convolutional Generative Adversarial Networks for Isolated Handwritten Arabic Character Generation","volume":"47","author":"Mustapha IB","year":"2022","unstructured":"Mustapha IB, Hasan S, Nabus H, Shamsuddin SM (2022) Conditional Deep Convolutional Generative Adversarial Networks for Isolated Handwritten Arabic Character Generation. Arab J Sci Eng 47:1309\u20131320. https:\/\/doi.org:10.1007\/s13369-021-05796-0","journal-title":"Arab J Sci Eng"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1515\/nanoph-2019-0117","article-title":"Designing nanophotonic structures using conditional deep convolutional generative adversarial networks","volume":"8","author":"So S","year":"2019","unstructured":"So S, Rho J (2019) Designing nanophotonic structures using conditional deep convolutional generative adversarial networks. Nanophotonics 8:1255\u20131261. https:\/\/doi.org:doi:10.1515\/nanoph-2019-0117","journal-title":"Nanophotonics"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1029\/2018WR024592","article-title":"Predicting CO2 Plume Migration in Heterogeneous Formations Using Conditional Deep Convolutional Generative Adversarial Network","volume":"55","author":"Zhong Z","year":"2019","unstructured":"Zhong Z, Sun AY, Jeong H (2019) Predicting CO2 Plume Migration in Heterogeneous Formations Using Conditional Deep Convolutional Generative Adversarial Network. Water Resour Res 55:5830\u20135851. https:\/\/doi.org:https:\/\/doi.org\/10.1029\/2018WR024592","journal-title":"Water Resour Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10845-020-01579-w","article-title":"A case study of conditional deep convolutional generative adversarial networks in machine fault diagnosis","volume":"32","author":"Luo J","year":"2021","unstructured":"Luo J, Huang J, Li H (2021) A case study of conditional deep convolutional generative adversarial networks in machine fault diagnosis. J Intell Manuf 32:407\u2013425. https:\/\/doi.org:10.1007\/s10845-020-01579-w","journal-title":"J Intell Manuf"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab054","article-title":"Machine learning on ligand-residue interaction profiles to significantly improve binding affinity prediction","volume":"22","author":"Ji B","year":"2021","unstructured":"Ji B et al (2021) Machine learning on ligand-residue interaction profiles to significantly improve binding affinity prediction. Brief Bioinform 22. https:\/\/doi.org:10.1093\/bib\/bbab054","journal-title":"Brief Bioinform"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou T","year":"2011","unstructured":"Hou T, Wang J, Li Y, Wang W (2011) Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 51:69\u201382. https:\/\/doi.org:10.1021\/ci100275a","journal-title":"J Chem Inf Model"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1021\/jp010454y","article-title":"Extending the Applicability of the Nonlinear Poisson\u2009\u2013\u2009Boltzmann Equation: Multiple Dielectric Constants and Multivalent Ions","volume":"105","author":"Rocchia W","year":"2001","unstructured":"Rocchia W, Alexov E, Honig B (2001) Extending the Applicability of the Nonlinear Poisson\u2009\u2013\u2009Boltzmann Equation: Multiple Dielectric Constants and Multivalent Ions. J Phys Chem B 105:6507\u20136514. https:\/\/doi.org:10.1021\/jp010454y","journal-title":"J Phys Chem B"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1021\/jm049081q","article-title":"Validation and Use of the MM-PBSA Approach for Drug Discovery","volume":"48","author":"Kuhn B","year":"2005","unstructured":"Kuhn B, Gerber P, Schulz-Gasch T, Stahl M (2005) Validation and Use of the MM-PBSA Approach for Drug Discovery. J Med Chem 48:4040\u20134048. https:\/\/doi.org:10.1021\/jm049081q","journal-title":"J Med Chem"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0006-3495(04)74084-9","article-title":"Revisiting free energy calculations: a theoretical connection to MM\/PBSA and direct calculation of the association free energy","volume":"86","author":"Swanson JM","year":"2004","unstructured":"Swanson JM, Henchman RH, McCammon JA (2004) Revisiting free energy calculations: a theoretical connection to MM\/PBSA and direct calculation of the association free energy. Biophys J 86:67\u201374. https:\/\/doi.org:10.1016\/s0006-3495(04)74084-9","journal-title":"Biophys J"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-Point Binding Free Energy Calculation with MM\/PBSA and MM\/GBSA: Strategies and Applications in Drug Design","volume":"119","author":"Wang E","year":"2019","unstructured":"Wang E et al (2019) End-Point Binding Free Energy Calculation with MM\/PBSA and MM\/GBSA: Strategies and Applications in Drug Design. Chem Rev 119:9478\u20139508. https:\/\/doi.org:10.1021\/acs.chemrev.9b00055","journal-title":"Chem Rev"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2174\/157340906778226454","article-title":"Recent Advances in Free Energy Calculations with a Combination of Molecular Mechanics and Continuum Models","volume":"2","author":"Junmei W","year":"2006","unstructured":"Junmei W, Tingjun H, Xiaojie X (2006) Recent Advances in Free Energy Calculations with a Combination of Molecular Mechanics and Continuum Models. Curr Comput -Aided Drug Des 2:287\u2013306. https:\/\/doi.org:http: \/\/dx.doi.org\/10.2174\/157340906778226454","journal-title":"Curr Comput -Aided Drug Des"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1021\/jm0100279","article-title":"Are Free Energy Calculations Useful in Practice? A Comparison with Rapid Scoring Functions for the p38 MAP Kinase Protein System","volume":"44","author":"Pearlman DA","year":"2001","unstructured":"Pearlman DA, Charifson PS (2001) Are Free Energy Calculations Useful in Practice? A Comparison with Rapid Scoring Functions for the p38 MAP Kinase Protein System. J Med Chem 44:3417\u20133423. https:\/\/doi.org:10.1021\/jm0100279","journal-title":"J Med Chem"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1021\/jm061021s","article-title":"Protein-Ligand Binding Affinity Predictions by Implicit Solvent Simulations: A Tool for Lead Optimization?","volume":"49","author":"Michel J","year":"2006","unstructured":"Michel J, Verdonk ML, Essex JW (2006) Protein-Ligand Binding Affinity Predictions by Implicit Solvent Simulations: A Tool for Lead Optimization? J Med Chem 49:7427\u20137439. https:\/\/doi.org:10.1021\/jm061021s","journal-title":"J Med Chem"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1021\/acsomega.9b04233","article-title":"Fast, Accurate, and Reliable Protocols for Routine Calculations of Protein-Ligand Binding Affinities in Drug Design Projects Using AMBER GPU-TI with ff14SB\/GAFF","volume":"5","author":"He X","year":"2020","unstructured":"He X et al (2020) Fast, Accurate, and Reliable Protocols for Routine Calculations of Protein-Ligand Binding Affinities in Drug Design Projects Using AMBER GPU-TI with ff14SB\/GAFF. Acs Omega 5:4611\u20134619. https:\/\/doi.org:10.1021\/acsomega.9b04233","journal-title":"Acs Omega"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law V","year":"2014","unstructured":"Law V et al (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res 42:D1091\u20131097. https:\/\/doi.org:10.1093\/nar\/gkt1068","journal-title":"Nucleic Acids Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: A Free Tool to Discover Chemistry for Biology","volume":"52","author":"Irwin JJ","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: A Free Tool to Discover Chemistry for Biology. J Chem Inf Model 52:1757\u20131768. https:\/\/doi.org:10.1021\/ci3001277","journal-title":"J Chem Inf Model"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski CA","year":"2004","unstructured":"Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technol 1:337\u2013341. https:\/\/doi.org https:\/\/doi.org\/10.1016\/j.ddtec.2004.11.007","journal-title":"Drug Discovery Today: Technol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0169-7439(87)80084-9","article-title":"Principal component analysis","volume":"2","author":"Wold S","year":"1987","unstructured":"Wold S, Esbensen K, Geladi P (1987) Principal component analysis. Chemometr Intell Lab Syst 2:37\u201352. https:\/\/doi.org https:\/\/doi.org\/10.1016\/0169-7439(87)80084-9","journal-title":"Chemometr Intell Lab Syst"},{"key":"ref54","author":"Refaeilzadeh P","year":"2009","unstructured":"Refaeilzadeh P, Tang L, Liu H (2009) in Encyclopedia of Database Systems (eds Ling Liu & M. Tamer \u00d6Zsu) 532\u2013538Springer US"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O'Boyle NM","year":"2011","unstructured":"O'Boyle NM et al (2011) Open Babel: An open chemical toolbox. J Cheminf 3:33. https:\/\/doi.org:10.1186\/1758-2946-3-33","journal-title":"J Cheminf"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1021\/acschemneuro.9b00696","article-title":"Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations","volume":"11","author":"Ji B","year":"2020","unstructured":"Ji B et al (2020) Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations. ACS Chem Neurosci 11:1139\u20131158. https:\/\/doi.org:10.1021\/acschemneuro.9b00696","journal-title":"ACS Chem Neurosci"},{"key":"ref57","author":"Lecun Y","year":"1999","unstructured":"Lecun Y et al (1999) Comparison Of Learning Algorithms For Handwritten Digit Recognition"},{"key":"ref58","first-page":"2825","article-title":"Vincent Dubourg, Jake Vanderplas, Alexandre Passos, David Cournapeau, Matthieu Brucher, Matthieu Perrot, \u00c9douard Duchesnay. Scikit-learn: Machine Learning in Python","volume":"12","author":"Fabian Pedregosa GV","year":"2011","unstructured":"Fabian Pedregosa GV, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R (2011) Vincent Dubourg, Jake Vanderplas, Alexandre Passos, David Cournapeau, Matthieu Brucher, Matthieu Perrot, \u00c9douard Duchesnay. Scikit-learn: Machine Learning in Python. J Mach Learn Res 12:2825\u20132830","journal-title":"J Mach Learn Res"},{"key":"ref59","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner MF","year":"1999","unstructured":"Sanner MF (1999) Python: a programming language for software integration and development. J Mol Graph Model 17:57\u201361","journal-title":"J Mol Graph Model"},{"key":"ref60","author":"Chollet F","year":"2015","unstructured":"Chollet F (2015) Keras"},{"key":"ref61","author":"Abadi M","year":"2016","unstructured":"Abadi M et al (2016) USENIX Association, Savannah, GA, USA,. in Proceedings of the 12th USENIX conference on Operating Systems Design and Implementation 265\u2013283"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1021\/ci9800211","article-title":"Chemical Similarity Searching","volume":"38","author":"Willett P","year":"1998","unstructured":"Willett P, Barnard JM, Downs GM (1998) Chemical Similarity Searching. J Chem Inf Comput Sci 38:983\u2013996. https:\/\/doi.org:10.1021\/ci9800211","journal-title":"J Chem Inf Comput Sci"},{"key":"ref63","author":"Arjovsky M","unstructured":"Arjovsky M, Chintala S, Bottou L in International conference on machine learning. 214\u2013223 (PMLR)"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton GR","year":"2012","unstructured":"Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL (2012) Quantifying the chemical beauty of drugs. Nat Chem 4:90\u201398. https:\/\/doi.org:10.1038\/nchem.1243","journal-title":"Nat Chem"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6516504\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6516504\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:22:36Z","timestamp":1777458156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6516504\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":64,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6516504\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,5,12]]},"subtype":"preprint"}}